An unidentified Bitcoin investor has submitted a proposal to US regulators recommending strict rules for crypto custodians, including reserve requirements, legal segregation of customer assets, and customer consent for lending or rehypothecation of Bitcoin. The investor's memo emphasizes independent audits, cryptographic attestations, and clear distinctions between custody and lending products to protect customers. This comes as the CFTC seeks public comment on broader digital asset market regulations, with feedback due by December 14. The proposal aims to enhance transparency and security in Bitcoin custody but is not yet policy or evidence of widespread market abuse.
Bitcoin custody safeguards are under scrutiny as an investor urges US regulators to impose stricter rules. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 09, 2026 02:21 WIB: out of 50 major cryptocurrencies, 8 rose and 41 fell. Notable price changes include BAL at Rp16.297 (+11.14%), EOS at Rp12.649 (+8.13%), and EGLD at Rp53.931 (-5.11%) with EGLD showing 0% sell and 100% buy order activity on Pluang.
NVIDIA's Board of Directors has started an independent investigation after reports that CEO Jensen Huang was targeted by a foreign intelligence operation. The inquiry, led by independent directors and external counsel, aims to ensure no national secu...
CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...
Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...
At the 13th annual Muhammad Ali Humanitarian Awards in Louisville, Colin Kaepernick was honored as Humanitarian of the Year for his activism and entrepreneurship, including founding literacy platform Lumi and Know Your Rights Camp. The event also rec...
Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...
